Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
All content for Few & Far Between: How Biotech Gets Built is the property of Chris O'Brien and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
Episode 49: Eileen Faucher, Principal and Founder, Brass Tacks Health
Few & Far Between: How Biotech Gets Built
35 minutes 37 seconds
10 months ago
Episode 49: Eileen Faucher, Principal and Founder, Brass Tacks Health
Today on the Biorasi Few & Far Between podcast:
What if you could read a story before its official release? Competitive intelligence gives you early access to information on emerging trends in clinical trials.
On today's episode, host Chris O'Brien welcomes Eileen Faucher. Eileen is the Principal and Founder of Brass Tacks Health, a company that provides insights that biotechs need to drive clinically-meaningful therapies.
Listen in to get the ROI on competitive intelligence, concise communications, and helping patients find relevant clinical trials.
Thanks for listening!
Few & Far Between: How Biotech Gets Built
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
